Min Li to Molecular Targeted Therapy
This is a "connection" page, showing publications Min Li has written about Molecular Targeted Therapy.
Connection Strength
0.764
-
Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Lett. 2015 Jul 10; 363(1):1-6.
Score: 0.430
-
Targeted therapies for cancer. BMC Med. 2022 03 11; 20(1):90.
Score: 0.174
-
Editorial - Special issue on Fighting Pancreatic Cancer. Cancer Lett. 2017 07 10; 398:22-23.
Score: 0.123
-
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2019 11 12; 116(46):23264-23273.
Score: 0.037